Carbinoxamine, an anticholinergic and antihistamine agent, is used for hayfever, angioedema, vasomotor rhinitis, mild urticaria, dermatographism and allergic conjunctivitis. It is a histamine antagonist, specifically an H1-antagonist.
Mizolastine dihydrochloride is a histamine H1-receptor antagonist (IC50: 47 nM). It also used in the treatment of hayfever, hives, and other allergic reactions.
Dexbrompheniramine is an antihistamine with anticholinergic properties. It is used to treat allergic diseases such as hayfever or urticaria. It can compete with histamine for H1 receptor sites on effector cells of the gastrointestinal tract, blood vessel
(E Z)-Ensifentrine is a potent and selective PDE3 4 inhibitor. (E Z)-Ensifentrine acts as a long-acting inhibitor of the phosphodiesterase enzymes PDE-3 and PDE-4, producing both bronchodilator and antiinflammatory effects. It is being developed by Verona Pharma as a potential treatment for asthma and hayfever, and is currently in clinical trials.